Enhanced Bimatoprost Ophthalmic Solution
First Claim
Patent Images
1. A composition comprising from 0.01% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration.
1 Assignment
0 Petitions
Accused Products
Abstract
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein.
A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
-
Citations
17 Claims
- 1. A composition comprising from 0.01% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration.
- 12. A method comprising administering to a mammal suffering from glaucoma or intraocular hypertension a composition comprising from 0.01% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride.
Specification